Depomed (DEPO) Tops Q3 EPS by 14c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/25/2026
- Nasdaq, S&P end lower as tech stocks fall
- Micron posts record profit as AI memory demand fuels explosive growth
- Brent settles at lowest since before start of Iran war as more tankers exit Hormuz
- All eyes on Micron earnings tonight as sell-off raises stakes for AI memory trade
- Alphabet added to Dow Jones Industrial Average, Verizon dropped
WallachBeth Capital Upgrades DepoMed Inc (DEPO) to Buy
November 11, 2015 7:34 AM ESTWallachBeth Capital upgraded DepoMed Inc (NASDAQ: DEPO) from Hold to Buy with a price target of $33.00.
For an analyst ratings summary and ratings history on DepoMed Inc click here. For more ratings news on DepoMed Inc click here.
Shares of DepoMed Inc closed at $21.21 yesterday.
... MoreDepomed (DEPO) Reports 3Q EPS Beat; Janney Capital Reiterates Buy
November 10, 2015 9:25 AM ESTJanney Capital reiterated a Buy rating and $35.00 price target on DepoMed Inc (NASDAQ: DEPO) following the company's 3Q earnings report. DEPO reports $104.9 mln in revenues and non-GAAP adjusted EPS of $0.33, easily beating consensus estimates of $$101.64 mln and non-GAAP adjusted earnings of $0.19 per share.
Analyst... More
